Compare DXPE & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DXPE | LMAT |
|---|---|---|
| Founded | 1908 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.6B |
| IPO Year | 1998 | 2006 |
| Metric | DXPE | LMAT |
|---|---|---|
| Price | $159.24 | $114.39 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $154.00 | $105.80 |
| AVG Volume (30 Days) | 159.4K | ★ 192.9K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.90% |
| EPS Growth | 27.25 | ★ 30.57 |
| EPS | ★ 5.37 | 2.52 |
| Revenue | ★ $1,247,043,000.00 | $249,602,000.00 |
| Revenue This Year | $9.31 | $14.21 |
| Revenue Next Year | $7.85 | $8.88 |
| P/E Ratio | ★ $28.10 | $44.30 |
| Revenue Growth | N/A | ★ 13.53 |
| 52 Week Low | $75.58 | $78.01 |
| 52 Week High | $171.70 | $118.01 |
| Indicator | DXPE | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 69.33 | 59.84 |
| Support Level | $112.79 | $81.60 |
| Resistance Level | $171.70 | N/A |
| Average True Range (ATR) | 5.97 | 2.98 |
| MACD | 1.38 | -0.12 |
| Stochastic Oscillator | 95.11 | 72.54 |
DXP Enterprises Inc is engaged in the business of distributing maintenance, repair and operating (MRO) products, equipment and service to customers in various end markets, including general industrial, energy, food & beverage, chemical, transportation, water and wastewater. The company operates through three business segments: Service Centers, Innovative Pumping Solutions and Supply Chain Services. The majority of revenue is derived from the Service Centers segment, which provides a wide range of MRO products in the rotating equipment, bearing, power transmission, hose, fluid power, metal working, fastener, industrial supply, safety products and safety services categories. Geographically, it generates the maximum revenue from the United States.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.